investigating the place of jak inhibitors in the treatment of myelofibrosis
Published 1 year ago • 186 plays • Length 0:53Download video MP4
Download video MP3
Similar videos
-
2:52
jak inhibitor combination therapy for the treatment of myelofibrosis
-
3:48
jak inhibition for the early treatment of myelofibrosis
-
4:42
the role of jak inhibitors in treating mpns and the need for disease-modifying agents
-
1:14
the application of jak inhibitors in the treatment of polycythemia vera and myelofibrosis
-
3:22
jak2 inhibition in the treatment of myelofibrosis
-
9:46
jak inhibitors how and why they work in less than 10 min
-
3:40
pros and cons of ruxolitinib for the treatment of mpns
-
2:13
exciting agents and treatment approaches emerging in the field of myelofibrosis
-
3:23
myelofibrosis: updates on jak inhibitors
-
7:10
bomedemstat in jak inhibitor-resistant myelofibrosis
-
1:31
promising agents under investigation for the treatment of myelofibrosis with cytopenia
-
1:18
novel approaches for the treatment of myelofibrosis: navitoclax ruxolitinib
-
1:15
drugs under investigation for patients with mf who have failed treatment with jak inhibitors
-
2:13
the future of mpn treatment: exciting agents and targets being investigated
-
4:16
jak inhibitor selection & sequencing in myelofibrosis
-
0:51
the need for disease-modifying drugs in myelofibrosis
-
2:00
novel treatment strategies in myelofibrosis
-
3:19
therapeutic options following failure to jak inhibitors
-
2:04
novel therapies for myelofibrosis patients who have failed jak inhibitors
-
1:01
latest advances in myelofibrosis treatment
-
3:00
the promise of momelotinib in the treatment of myelofibrosis
-
2:09
approved & emerging jak inhibitors for patients with high-risk mf who are transplant-ineligible